These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25663076)

  • 1. Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo.
    Kroon J; Buijs JT; van der Horst G; Cheung H; van der Mark M; van Bloois L; Rizzo LY; Lammers T; Pelger RC; Storm G; van der Pluijm G; Metselaar JM
    Prostate; 2015 Jun; 75(8):815-24. PubMed ID: 25663076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myeloma.
    Deshantri AK; Fens MH; Ruiter RWJ; Metselaar JM; Storm G; van Bloois L; Varela-Moreira A; Mandhane SN; Mutis T; Martens ACM; Groen RWJ; Schiffelers RM
    J Control Release; 2019 Feb; 296():232-240. PubMed ID: 30682443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploratory first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2- and 1-week interval in patients with metastatic castration resistant prostate cancer.
    Vrouwe JPM; Kamerling IMC; van Esdonk MJ; Metselaar JM; Stuurman FE; van der Pluijm G; Burggraaf J; Osanto S
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00845. PubMed ID: 34414692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
    Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
    Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.
    van der Horst G; van den Hoogen C; Buijs JT; Cheung H; Bloys H; Pelger RC; Lorenzon G; Heckmann B; Feyen J; Pujuguet P; Blanque R; Clément-Lacroix P; van der Pluijm G
    Neoplasia; 2011 Jun; 13(6):516-25. PubMed ID: 21677875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal nanomedicines in the treatment of prostate cancer.
    Kroon J; Metselaar JM; Storm G; van der Pluijm G
    Cancer Treat Rev; 2014 May; 40(4):578-84. PubMed ID: 24216226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes promote pulmonary glucocorticoid delivery.
    Suntres ZE; Shek PN
    J Drug Target; 1998; 6(3):175-82. PubMed ID: 9888303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide.
    Lin C; Zhang X; Chen H; Bian Z; Zhang G; Riaz MK; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
    Drug Deliv; 2018 Nov; 25(1):256-266. PubMed ID: 29334814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model.
    Jantscheff P; Ziroli V; Esser N; Graeser R; Kluth J; Sukolinskaya A; Taylor LA; Unger C; Massing U
    Clin Exp Metastasis; 2009; 26(8):981-92. PubMed ID: 19784785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor efficacy of dexamethasone-loaded core-crosslinked polymeric micelles.
    Coimbra M; Rijcken CJ; Stigter M; Hennink WE; Storm G; Schiffelers RM
    J Control Release; 2012 Nov; 163(3):361-7. PubMed ID: 23041274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
    Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
    Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agents targeting prostate cancer bone metastasis.
    Mohammad KS; Fournier PG; Guise TA; Chirgwin JM
    Anticancer Agents Med Chem; 2009 Dec; 9(10):1079-88. PubMed ID: 19719455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic dual-modified liposome improves targeting and therapeutic efficacy of bone metastasis from breast cancer.
    Ke X; Lin W; Li X; Wang H; Xiao X; Guo Z
    Drug Deliv; 2017 Nov; 24(1):1680-1689. PubMed ID: 29092646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling.
    Mancini A; Colapietro A; Pompili S; Del Fattore A; Delle Monache S; Biordi LA; Angelucci A; Mattei V; Liang C; Gravina GL; Festuccia C
    Tumour Biol; 2018 Apr; 40(4):1010428318771773. PubMed ID: 29687745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing solid tumor therapy with sequential delivery of dexamethasone and docetaxel engineered in a single carrier to overcome stromal resistance to drug delivery.
    Zhang L; Su H; Liu Y; Pang N; Li J; Qi XR
    J Control Release; 2019 Jan; 294():1-16. PubMed ID: 30527754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plumbagin attenuates cancer cell growth and osteoclast formation in the bone microenvironment of mice.
    Yan W; Wang TY; Fan QM; Du L; Xu JK; Zhai ZJ; Li HW; Tang TT
    Acta Pharmacol Sin; 2014 Jan; 35(1):124-34. PubMed ID: 24384612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
    Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
    Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.
    Shi C; Cao H; He W; Gao F; Liu Y; Yin L
    Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment.
    Gabay M; Weizman A; Zeineh N; Kahana M; Obeid F; Allon N; Gavish M
    Cell Mol Neurobiol; 2021 Jul; 41(5):1019-1029. PubMed ID: 33025416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.